Relevant data have not been disclosed by the company yet.
Name
Name/Position
Position
Shareholding
Change
Relevant data have not been disclosed by the company yet.
Revenue Breakdown
Currency: USDUpdated: Sat, Dec 13
Currency: USDUpdated: Sat, Dec 13
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
694.00K
96.12%
New Zealand
20.00K
2.77%
Europe
8.00K
1.11%
Other
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Dec 13
Updated: Sat, Dec 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.47%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
Other
98.25%
Shareholders
Shareholders
Proportion
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.47%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
Other
98.25%
Shareholder Types
Shareholders
Proportion
Holding Company
0.76%
Investment Advisor/Hedge Fund
0.47%
Hedge Fund
0.42%
Investment Advisor
0.11%
Other
98.23%
Institutional Shareholding
Updated: Sat, Dec 13
Updated: Sat, Dec 13
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
17
11.00K
1.01%
+8.02K
2025Q3
18
5.67K
0.52%
+2.09K
2025Q2
17
5.94K
1.12%
+2.33K
2025Q1
15
5.97K
2.98%
+3.91K
2024Q4
21
3.30K
9.68%
-2.05K
2024Q3
24
3.74K
14.76%
+735.00
2024Q2
24
2.12K
8.37%
-2.01K
2024Q1
27
3.30K
17.76%
+1.52K
2023Q4
31
975.00
5.24%
-2.42K
2023Q3
36
1.12K
7.42%
-4.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Alpha Capital Aktiengesellschaft
8.25K
0.76%
+4.93K
+148.55%
May 16, 2025
Geode Capital Management, L.L.C.
--
0%
-205.00
-100.00%
Mar 31, 2025
Armistice Capital LLC
3.99K
0.37%
+3.99K
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.00K
0.09%
+1.00K
--
Sep 30, 2025
Tower Research Capital LLC
627.00
0.06%
+401.00
+177.43%
Sep 30, 2025
The Vanguard Group, Inc.
--
0%
-274.00
-100.00%
Mar 31, 2025
UBS Financial Services, Inc.
35.00
0%
-1.33K
-97.45%
Sep 30, 2025
Fashek (Christopher M)
34.00
0.01%
--
--
May 16, 2025
SBI Securities Co., Ltd.
15.00
0%
+15.00
--
Sep 30, 2025
BofA Global Research (US)
6.00
0%
+5.00
+500.00%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of ENvue Medical Ord Shs?
The top five shareholders of ENvue Medical Ord Shs are: Alpha Capital Aktiengesellschaft holds 8.25K shares, accounting for 0.76% of the total shares. Geode Capital Management, L.L.C. holds 0.00 shares, accounting for 0.00% of the total shares. Armistice Capital LLC holds 3.99K shares, accounting for 0.37% of the total shares. Morgan Stanley Smith Barney LLC holds 1.00K shares, accounting for 0.09% of the total shares. Tower Research Capital LLC holds 627.00 shares, accounting for 0.06% of the total shares.
What are the top three shareholder types of ENvue Medical Ord Shs?
The top three shareholder types of ENvue Medical Ord Shs are: Alpha Capital Aktiengesellschaft Geode Capital Management, L.L.C. Armistice Capital LLC
How many institutions hold shares of ENvue Medical Ord Shs (FEED)?
As of 2025Q4, 17 institutions hold shares of ENvue Medical Ord Shs, with a combined market value of approximately 11.00K, accounting for 1.01% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.49%.
What is the biggest source of revenue for ENvue Medical Ord Shs?
In FY2025Q3, the -- business generated the highest revenue for ENvue Medical Ord Shs, amounting to -- and accounting for --% of total revenue.